Detalhe da pesquisa
1.
Growth dynamics in naturally progressing chronic lymphocytic leukaemia.
Nature
; 570(7762): 474-479, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31142838
2.
Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapy.
Blood
; 140(25): 2663-2671, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35930750
3.
AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasms.
Blood
; 138(3): 246-258, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34292322
4.
Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy.
Blood
; 137(20): 2817-2826, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259589
5.
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?
Curr Oncol Rep
; 24(12): 1705-1713, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36334220
6.
Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia.
Blood
; 134(8): 688-698, 2019 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292113
7.
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.
Blood
; 131(25): 2745-2760, 2018 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29540348
8.
Chronic lymphocytic leukemia (CLL) treatment: So many choices, such great options.
Cancer
; 125(9): 1432-1440, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30807655
9.
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.
Blood
; 129(5): 553-560, 2017 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27903528
10.
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.
N Engl J Med
; 373(18): 1733-47, 2015 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26352686
11.
High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia.
Blood
; 128(25): 2931-2940, 2016 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27815263
12.
Binding of CLL subset 4 B-cell receptor immunoglobulins to viable human memory B lymphocytes requires a distinctive IGKV somatic mutation.
Mol Med
; 23: 1-12, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28097289
13.
Correction to: Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells.
Mol Med
; 28(1): 35, 2022 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35291936
14.
Chronic lymphocytic leukemia immunoglobulins display bacterial reactivity that converges and diverges from auto-/poly-reactivity and IGHV mutation status.
Clin Immunol
; 172: 44-51, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27586592
15.
Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia.
Blood
; 124(1): 42-8, 2014 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24868078
16.
FcγRIIb-BCR coligation inhibits BCR signaling in chronic lymphocytic leukemia.
Haematologica
; 106(1): 306-309, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32336680
17.
Chronic lymphocytic leukemia (CLL)-Then and now.
Am J Hematol
; 91(3): 330-40, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26690614
18.
Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like Receptor.
Mol Med
; 21(1): 46-57, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25611435
19.
T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.
Blood
; 120(12): 2438-49, 2012 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875913
20.
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions.
Blood
; 120(24): 4802-11, 2012 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23071276